BioLine Rx Ltd (BLRX)
0.3232
-0.22
(-40.71%)
USD |
NASDAQ |
Nov 21, 16:00
0.32
0.00 (0.00%)
Pre-Market: 08:26
BioLine Rx Enterprise Value: 15.23M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 15.23M |
| November 20, 2024 | 32.97M |
| November 19, 2024 | 32.27M |
| November 18, 2024 | 26.38M |
| November 15, 2024 | 27.40M |
| November 14, 2024 | 26.00M |
| November 13, 2024 | 25.68M |
| November 12, 2024 | 23.87M |
| November 11, 2024 | 24.96M |
| November 08, 2024 | 24.93M |
| November 07, 2024 | 25.47M |
| November 06, 2024 | 25.60M |
| November 05, 2024 | 24.49M |
| November 04, 2024 | 23.55M |
| November 01, 2024 | 23.45M |
| October 31, 2024 | 22.18M |
| October 30, 2024 | 23.67M |
| October 29, 2024 | 24.12M |
| October 28, 2024 | 24.23M |
| October 25, 2024 | 21.76M |
| October 24, 2024 | 21.36M |
| October 23, 2024 | 23.26M |
| October 22, 2024 | 25.38M |
| October 21, 2024 | 27.04M |
| October 18, 2024 | 26.95M |
| Date | Value |
|---|---|
| October 17, 2024 | 26.32M |
| October 16, 2024 | 26.96M |
| October 15, 2024 | 24.37M |
| October 14, 2024 | 26.20M |
| October 11, 2024 | 28.36M |
| October 10, 2024 | 26.56M |
| October 09, 2024 | 26.14M |
| October 08, 2024 | 26.88M |
| October 07, 2024 | 27.64M |
| October 04, 2024 | 26.16M |
| October 03, 2024 | 29.76M |
| October 02, 2024 | 31.24M |
| October 01, 2024 | 32.56M |
| September 30, 2024 | 32.24M |
| September 27, 2024 | 38.95M |
| September 26, 2024 | 39.75M |
| September 25, 2024 | 40.55M |
| September 24, 2024 | 41.52M |
| September 23, 2024 | 40.77M |
| September 20, 2024 | 42.39M |
| September 19, 2024 | 41.41M |
| September 18, 2024 | 39.21M |
| September 17, 2024 | 38.93M |
| September 16, 2024 | 40.55M |
| September 13, 2024 | 39.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.27M
Minimum
Dec 27 2022
157.02M
Maximum
May 04 2021
42.09M
Average
35.37M
Median
Nov 12 2020
Enterprise Value Benchmarks
| Compugen Ltd | 17.12M |
| Pluri Inc | 31.05M |
| XTL Biopharmaceuticals Ltd | 7.633M |
| Can Fite Biofarma Ltd | 7.282M |
| BiomX Inc | 4.047M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.484M |
| Revenue (Quarterly) | 5.393M |
| Total Expenses (Quarterly) | 11.17M |
| EPS Diluted (Quarterly) | 0.0061 |
| Gross Profit Margin (Quarterly) | 83.37% |
| Profit Margin (Quarterly) | 8.97% |
| Earnings Yield | -140.3% |